<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01373645</url>
  </required_header>
  <id_info>
    <org_study_id>RJH20100909</org_study_id>
    <nct_id>NCT01373645</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Registry of Yinyi Stent</brief_title>
  <acronym>SERY-I</acronym>
  <official_title>Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University School of Medicine</source>
  <brief_summary>
    <textblock>
      Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and
      delayed restenosis. Persistent polymer could be responsible. Local delivery of paclitxel from
      a polymer-free Yinyi stent (Dalian Yinyi biomaterial research and development co.ltd) may
      prevent these complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>major adverse cardiac events</measure>
    <time_frame>12 months</time_frame>
    <description>including cardiac death, myocardial infarction and target vessel failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stent thrombosis</measure>
    <time_frame>12 months</time_frame>
    <description>according to ARC definition</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1045</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Yinyi stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects with Yinyi stent implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Yinyi stent</intervention_name>
    <description>subjects with Yinyi stent implantation</description>
    <arm_group_label>Yinyi stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-80 years old

          -  both gender

          -  native coronary lesion

          -  narrowing &gt; 70%

          -  vessel size 2.5-4.0 in diameter

        Exclusion Criteria:

          -  without informed consent,

          -  ST elevation myocardial infarction within 7 days,

          -  patient with â‰¤ 70% coronary narrowing at target lesion,

          -  left main lesion,

          -  multivessel narrowing need more than 3 stent implantations,

          -  by-pass graft,

          -  abnormal liver function before randomization,

          -  active hepatitis or muscular disease,

          -  impaired renal function with serum creatinine level &gt; 3mg/dl,

          -  impaired left ventricular function with LVEF &lt; 30%,

          -  Participate in other studies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ruijin hospital, Shanghai Jiao Tong University, School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Zhang RY, Zhang Q, Zhu JZ, Chen LL, Zhang CY, Zhou XC, Yuan Y, Zhong ZX, Li L, Qiu J, Wang W, Chen XM, Yang ZJ, Yan JC, Chen SL, Hou YQ, Wu YQ, Luo HM, Qiu JP, Zhu L, Wang Y, Fu GS, Wang JA, Ma KH, Yin YH, Zhang DF, Hu XS, Zhu GY, Shen WF; Safety and Efficacy Registry of Yinyi stent (SERY-I) Investigators. Safety and efficacy of polymer-free paclitaxel-eluting microporous stent in real-world practice: 1-year follow-up of the SERY-I registry. Chin Med J (Engl). 2011 Nov;124(21):3521-6.</citation>
    <PMID>22340171</PMID>
  </results_reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2011</study_first_submitted>
  <study_first_submitted_qc>June 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2011</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2015</last_update_posted>
  <responsible_party>
    <name_title>Weifeng Shen</name_title>
    <organization>Ruijin hospital, shanghai jiao tong university school of medicine</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

